Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOE-01 for postoperative inflammation and pain after age-related cataract surgery
CTR20190510Phase 3Active
- Sponsor
- Tianjin Pharmaceutical Research Institute
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bromfenac sodium in Postoperative ocular inflammation, post-operative ocular pain, sponsored by Tianjin Pharmaceutical Research Institute. Started Apr 2019; status: active.
02
Drugs
bromfenac sodium
03
Conditions
Postoperative ocular inflammationpost-operative ocular pain
Beyond the preview
Go deeper on CTR20190510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190510.